RE:Poking myself in the eye each day with THThey have a big problem on this front in that they have made projections about future revenues in the past for Egrifta in lipo and Trogarzo and then they came up well short of those forecasts. So, they have a credibility issue regarding forecasts. They might decide to give us some new forecasts for cancer on 6/21 but will the market even react to that like it does to the other companies you are following? Probably not due to their los credibility. Besides, it is too early to discuss such matters on cancer, although guidance about the market sizes they could get involved in with TH-1902 would be helpful so investors can start to understand the upside possibilities. They will still need to make a detailed market forecast at some point but they then also need to come somewhere close to it to regain investor credibility. I am certain they are not anywhere near making any specific revenue forecasts about cancer or NASH yet, nor should they be.
But they can start trying to rebuild their credibility by announcing Egrifta in Lipo and Trogarzo sales guidance, which is below what they are confident they can actually achieve. That would force the analysts who are carrying goofy forecasts to fix their numbers and would put them in a place where the next time they report earnings the headline is they beat on revenues and they beat on earnings, which should be the goal. Once a company gets a reputation for consistently doing that, the stock typically benefits as analysts will have greater confidence that the company will not blow them up in the future as THTX has consistently done to the analysts in the past.
realitycheck4u wrote: All of my investments I've been decided on the potential future including TH. However all of my other investments talk about the future revenue potential except TH. So why would anybody who does not have the time to actually read between the lines invest in TH when it should be TH who tells me what their success should financially mean to the company yet TH does not do that. That's their problem. They don't know how to get people excited about the potential future with real numbers as the hypothetical potential.